全球皮下注射針市場規模、份額和趨勢分析報告－產業概況和2032年預測

全球皮下注射針市場規模

• 2024 年全球皮下注射針市場價值為78 億美元，預計到 2032 年將達到 147.6 億美元
• 在 2025 年至 2032 年的預測期內，市場可能以8.3% 的複合年增長率成長，主要受全球醫療保健結構不斷增長的推動
• 這種成長受到家庭醫療保健市場不斷增長、醫療和外科手術增加等因素的推動

皮下注射針市場分析

• 皮下注射針是用於將藥物、疫苗和其他治療注射到體內的重要醫療工具。它們在各種醫療程序中發揮關鍵作用，包括疫苗接種、胰島素注射以及糖尿病和癌症等慢性疾病的其他治療。
• 皮下注射針的需求主要源自於慢性病發病率的上升、疫苗接種計畫的推廣以及醫療技術的進步。全球需求的很大一部分來自糖尿病管理，數百萬人需要每日註射胰島素。此外，包括新冠疫情在內的全球疫苗接種計劃的不斷推進，進一步刺激了皮下注射針頭的需求。
• 北美是皮下注射針使用量最大的地區之一，這得益於其先進的醫療基礎設施、高昂的醫療支出以及先進醫療技術的廣泛應用。在美國，糖尿病等慢性疾病的廣泛流行以及大規模的疫苗接種計劃極大地促進了該地區對皮下注射針頭的高需求。此外，北美市場在針頭安全創新和自我注射裝置方面也處於領先地位，這進一步推動了市場的成長。
• 例如，美國糖尿病患者數量穩定成長，導致胰島素筆和注射器的需求增加。智慧注射器和安全針頭的引入，以防止針刺傷，進一步推動了北美市場的發展。
• 在全球範圍內，皮下注射針被認為是醫療保健環境中最關鍵的工具之一。它們對於確保注射的有效進行至關重要，在許多醫療保健環境中，它們被列為僅次於輸液泵的第二大重要醫療設備。它們在精準給藥和確保患者註射安全方面發揮著重要作用，使其成為醫院和家庭醫療保健環境中不可或缺的一部分。

報告範圍和皮下注射針市場細分         

皮下注射針市場趨勢

“智慧注射器和數位整合的普及率不斷提高”

• 全球皮下注射針市場的一個突出趨勢是智慧注射器和數位整合的日益普及
• These advanced technologies enhance the precision and efficiency of drug delivery by providing real-time monitoring and tracking of dosage, improving patient safety, and ensuring adherence to prescribed medication schedules. Smart syringes often come with features such as dose tracking, auto-disable mechanisms, and data storage capabilities, which help to reduce medication errors and improve the overall quality of care
• For instance, smart syringes can be equipped with Bluetooth or RFID technology, allowing healthcare providers to monitor the exact dosage administered and track patient adherence to medication schedules remotely. This technology is especially beneficial for chronic disease management, such as diabetes, where precise and timely insulin delivery is critical
• Digital integration also allows for the seamless capture and sharing of patient data, enhancing the efficiency of healthcare systems and enabling more personalized treatment plans. This integration supports the growing trend of telemedicine and remote monitoring, making it easier for patients to manage their conditions from home
• This trend is revolutionizing the way hypodermic needles are used, improving patient outcomes and safety, while increasing the demand for technologically advanced needles and injection devices in the market

Hypodermic Needles Market Dynamics

Driver

“Increasing Demand Due to Rising Chronic Diseases and Vaccination Needs”

• The growing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer is significantly driving the demand for hypodermic needles, as these conditions often require injectable medications
• The global vaccination campaigns, including those for COVID-19, have further amplified the need for hypodermic needles to administer vaccines efficiently and safely
• Technological advancements in needle design, such as safety-engineered needles, are addressing concerns related to needlestick injuries, enhancing patient and healthcare worker safety

For instance:

• In 2024, according to a report by the World Health Organization, over 11 billion COVID-19 vaccine doses were administered globally, highlighting the critical role of hypodermic needles in vaccination efforts
• In 2023, the International Diabetes Federation reported that approximately 537 million adults worldwide were living with diabetes, emphasizing the growing need for injectable insulin and other therapeutic drugs

• In conclusion, the rising prevalence of chronic diseases and the global vaccination efforts, particularly in the wake of the COVID-19 pandemic, have created a sustained demand for hypodermic needles

Opportunity

“Advancing Needle Technology for Enhanced Safety and Comfort”

• The development of safety-engineered hypodermic needles is revolutionizing the market by minimizing needlestick injuries and improving patient comfort during injections
• Needle-free injection systems are emerging as a promising alternative, offering painless drug delivery and reducing the risk of cross-contamination
• Customization of needles for specific applications, such as smaller gauge needles for reduced discomfort, is creating new opportunities for market growth.

For instance:

• In 2025, Becton Dickinson launched its UltraSafe Plus Passive Needle Guard, designed to enhance safety during injections and reduce the risk of needlestick injuries
• In 2024, Terumo Corporation introduced its Smart Infusion System, integrating advanced needle technology for precise and comfortable drug delivery

• In conclusion, the continued innovation in safety-engineered needles, needle-free injection systems, and customizable designs is driving significant advancements in patient safety and comfort, fueling growth in the hypodermic needle market

Restraint/Challenge

“Environmental Concerns and High Costs Limiting Market Penetration”

• The disposal of hypodermic needles poses significant environmental challenges, as improper disposal can lead to contamination and health risks
• The high cost of advanced needle technologies, such as safety-engineered needles, can deter adoption in low-income regions and smaller healthcare facilities
• Stringent regulatory requirements for needle manufacturing and disposal further add to the operational costs, limiting market growth

For instance:

• In 2023, according to a report by the Environmental Protection Agency, improper disposal of medical sharps, including hypodermic needles, contributed to increased risks of environmental contamination and public health concerns
• In 2024, a study published in the Journal of Medical Devices highlighted the financial burden of adopting safety-engineered needles in developing countries, restricting their widespread use

In conclusion, while advancements in needle technology are improving safety and patient care, environmental concerns, high costs, and stringent regulations continue to pose challenges that limit the widespread adoption of these innovations, particularly in low-income regions

Hypodermic Needles Market Scope

The market is segmented on the basis of product type, application and end user.

Hypodermic Needles Market Regional Analysis

“North America is the Dominant Region in the Hypodermic Needles Market”

• North America dominates the global hypodermic needles market, driven by its advanced healthcare infrastructure, high adoption of cutting-edge medical technologies, and the strong presence of key market players in the region
• 美國佔據了相當大的市場份額，這得益於糖尿病、心血管疾病和癌症等需要頻繁注射的慢性疾病的日益流行。此外，對自我注射設備（例如胰島素筆和自動注射器）的需求不斷增長，以及針頭安全技術（包括安全針頭）的創新，也是推動美國市場成長的因素。
• 完善的報銷政策和高水準的醫療支出進一步增強了北美市場。此外，政府注重疫苗接種計劃和醫療可近性的措施也刺激了對皮下注射針頭的需求。
• 此外，手術數量的增加（例如注射麻醉和手術中的藥物輸送）以及家庭醫療保健的興起趨勢有助於擴大整個地區的市場機會

“亞太地區預計將實現最高成長率”

• 預計亞太地區將見證注射針市場的最高成長率，這得益於醫療基礎設施的快速擴張、人們對慢性病的認識不斷提高以及醫療器材採用率的提高
• 由於人口老化加劇以及糖尿病和其他慢性疾病的盛行率上升，中國、印度和日本等國家正在成為皮下注射針的主要市場。這些國家對胰島素注射、疫苗接種和其他藥物輸送系統的需求正在推動市場的發展。
• 中國人口基數龐大，糖尿病患者數量不斷增長，正在大力投資現代醫療基礎設施。政府致力於提高醫療服務的可近性，先進醫療技術的普及也日益普及，這推動了皮下注射針的需求成長。
• 印度的慢性病病例（尤其是糖尿病）也在增加，同時人們對自我注射設備的偏好也日益增長。此外，全球醫療器材製造商的不斷湧現以及醫療保健系統的改善，也推動了該地區皮下注射針市場的成長。
• 日本擁有先進的醫療保健體系和高水準的技術採用，繼續成為先進皮下注射針的重要市場，特別是在外科和糖尿病護理領域

皮下注射針市場份額

市場競爭格局按競爭對手提供詳細資料。詳細資訊包括公司概況、公司財務狀況、收入、市場潛力、研發投入、新市場計劃、全球影響力、生產基地和設施、生產能力、公司優勢和劣勢、產品發布、產品寬度和廣度以及應用主導地位。以上提供的數據點僅與公司在市場中的重點相關。

市場中主要的市場領導者有：

• 美敦力（愛爾蘭）
• BD（美國）
• B. Braun SE（德國）
• 史賽克（美國）
• 強生服務公司（美國）
• 波士頓科學公司（美國）
• 泰爾茂株式會社（日本）
• 奧林巴斯株式會社（日本）
• Merit Medical Systems（美國）
• Greiner AG（奧地利）
• 默克集團（德國）
• 漢密爾頓公司（美國）
• 瑞士尤尼美德
• Argon Medical Devices Inc.（美國）
• NIPRO（日本）
• 史密斯集團有限公司（美國）
• Ultimed Inc.（美國）
• HAKKO株式會社（日本）
• TE Con​​nectivity（愛爾蘭）
• DTR醫療有限公司（英國）
• Rocket Medical plc.（英國）

全球皮下注射針市場的最新發展

• 2025年2月，碧迪 (BD) 宣布推出其先進的安全皮下注射針頭 BD UltraSafe Plus，旨在最大限度地減少針刺傷並提高患者舒適度。這項創新整合了被動式針頭保護裝置，增強了安全性，預計將在全球醫療保健市場中獲得顯著發展。
• 2024年11月，泰爾茂株式會社推出了智慧輸液系統，採用精密設計的皮下注射針，可實現精準舒適的藥物輸送。該系統旨在改善患者治療效果並簡化醫療流程。
• 2024年10月，史密斯醫療在Medica展會上推出了全新的皮下注射針技術。該產品採用超薄壁針頭，可減輕患者不適感並提高藥物流速，滿足了市場對高效能、患者友善注射解決方案日益增長的需求。
• 2024年9月，尼普洛集團推出了其環保皮下注射針系列產品，該系列產品採用永續材料，在維持高性能和安全標準的同時，減少對環境的影響。這項舉措與全球對更綠色醫療解決方案的追求相契合。

SKU-50269